Skip to content

Sofosbuvir plus ribavirin works well for hard-to-treat inner-city hepatitis C patients

Anu Osinusi, National Institute of Allergy and Infectious Diseases, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

AbbVie interferon-free combinations cure most newly treated hepatitis C patients

Eric Lawitz, Alamo Medical Research, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Lukewarm reaction to government’s sexual health framework for England

HIV increases the risk of heart attack, even in people with a suppressed viral load

Even moderate alcohol consumption increases risk of death for people with chronic hepatitis C

French researchers report 14 patients in 'remission' after controlling HIV for over 4 years off treatment

Are we underestimating the proportion of virally-suppressed patients in the US?

Lopinavir/ritonavir equivalent to nevirapine in Ugandan children

Gene therapy studies show potential for HIV control without drugs

Patrick Younan, Fred Hutchinson Cancer Res Ctr, Seattle, presenting at CROI 2013.